FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

864011003: Cabozantinib s-malate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3951852016 Cabozantinib s-malate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3951853014 Cabozantinib s-malate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5447001010 Cabozantinib malate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cabozantinib s-malate Is a Enzyme inhibitor false Inferred relationship Some
Cabozantinib s-malate Is a Pyridine true Inferred relationship Some
Cabozantinib s-malate Is a Quinoline true Inferred relationship Some
Cabozantinib s-malate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Protein-tyrosine kinase inhibitor (disposition) true Inferred relationship Some
Cabozantinib s-malate Is a Protein-tyrosine kinase inhibitor true Inferred relationship Some
Cabozantinib s-malate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Cabozantinib (substance) true Inferred relationship Some
Cabozantinib s-malate Is a Antineoplastic agent (substance) true Inferred relationship Some
Cabozantinib s-malate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Vascular endothelial growth factor receptor antagonist (disposition) true Inferred relationship Some
Cabozantinib s-malate Is a Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Cabozantinib (as cabozantinib s-malate) 20 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cabozantinib s-malate Inferred relationship Some 1
Product containing precisely cabozantinib (as cabozantinib s-malate) 80 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cabozantinib s-malate Inferred relationship Some 1
Cabozantinib (as cabozantinib s-malate) 20 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cabozantinib s-malate Inferred relationship Some 1
Product containing precisely cabozantinib (as cabozantinib s-malate) 40 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cabozantinib s-malate Inferred relationship Some 1
Product containing precisely cabozantinib (as cabozantinib s-malate) 60 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cabozantinib s-malate Inferred relationship Some 1

Reference Sets

GB English

US English

Back to Start